Modeling, simulation firm supporting radiation countermeasure development

By Melissa Fassbender contact

- Last updated on GMT

(Image: Getty/BreakingTheWalls)
(Image: Getty/BreakingTheWalls)

Related tags: Modeling and simulation

The modeling and simulation solutions provider Simulations Plus has been contracted to support countermeasure development for acute radiation syndrome in a partnership with a global pharma company.

An SLP company, DILIsym Services (DSS), is leading the development of RADAsym, a new quantitative systems pharmacology (QPS) platform.

Cognigen also will be working directly with the sponsor to curate data and support pharmacometric modeling activities.

The technology helps predict the effects of radiation in mice, non-human primates, and humans, in addition to the efficacy of interventions.

It will be used to help support approval for acute radiation syndrome (ARS) treatment under the Animal Rule, regulations which enable the approval of drugs and licensure of biological products in situations where human efficacy studies are not ethical or feasible.

The QPS platform will include major biological systems, including the vasculature and immune systems, the liver and GI tract, as well as the lung and bone marrow.

In the future, the RADAsym platform will be available for licensing and consulting services.

Said Shawn O’Connor, Simulations Plus CEO: "We are pleased to have been engaged by industry to support this critical development effort. Our expertise across QSP and PKPD techniques and model development positions us uniquely to satisfy the requirements of this endeavor. This engagement also demonstrates our ability to cross-sell the capabilities of our divisions.”

Related news

Show more

Related products

show more

ODM and CDASH in CRF design

ODM and CDASH in CRF design

Formedix | 15-Aug-2022 | Technical / White Paper

The lesser-known Operational Data Model (ODM) standard is often overlooked as it's not required by any regulators. So, why should you be interested...

Standardizing data with NCI controlled terminology

Standardizing data with NCI controlled terminology

Formedix | 18-Jul-2022 | Technical / White Paper

The use of consistent terminology within and between studies is critical to enabling an efficient trial process. CDISC standards such as CDASH, SDTM, SEND...

How clinical trial software can optimize trials

How clinical trial software can optimize trials

Formedix | 20-Jun-2022 | Technical / White Paper

This article explains the different types of clinical trial software available, and how it can be used to optimize the end to end clinical trials design...

Related suppliers

Follow us


View more